A
HALO icon

AlphaQuest’s Halozyme HALO Stock Holding History

AlphaQuest’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,242
Closed -$622K – 869
2025
Q4 		$622K Sell
9,242
-30,077
-76% -$2.02M 0.03% 668
2025
Q3 		$2.88M Buy
39,319
+34,011
+641% +$2.26M 0.19% 111
2025
Q2 		$276K Buy
5,308
+5,133
+2,933% +$292K 0.03% 934
2025
Q1 		$11.2K Hold
175
– – ﹤0.01% 1784
2024
Q4 		$8.37K Sell
175
-9,618
-98% -$493K ﹤0.01% 1500
2024
Q3 		$561K Buy
9,793
+9,134
+1,386% +$524K 0.05% 612
2024
Q2 		$34.5K Sell
659
-4,190
-86% -$184K ﹤0.01% 1199
2024
Q1 		$197K Sell
4,849
-6,940
-59% -$260K 0.03% 649
2023
Q4 		$436K Buy
+11,789
New +$444K 0.09% 395

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AlphaQuest's HALO Position: Q1 2026 in Review

AlphaQuest sold out of Halozyme (HALO) in Q1 2026, closing a stake of 9,242 shares — an estimated $622K sold.

AlphaQuest first reported a position in HALO in Q4 2023 and held it in 9 quarters. The position peaked at $2.88M in Q3 2025. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • AlphaQuest reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 9,242 Halozyme shares in Q1 2026, an estimated $622K.
  • AlphaQuest first reported a position in Halozyme in Q4 2023 and held it in 9 quarters.
  • AlphaQuest's Halozyme position peaked at $2.88M in Q3 2025.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.